Posters
CKD: Clinical - Therapies, CKM Health, Special Populations, and More
October 24, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Absence of Nocturnal Systolic Blood Pressure Dipping Is Associated with Impaired Cognitive Function in Patients with Stages 3-4 CKD
Controlling Hypertension Through Education and Coaching in Patients with CKD: Results from the CHECK-D Trial
Association Between Differences in eGFR by Creatinine vs. Cystatin C and Stroke Outcomes: Results from the Third China National Stroke Registry
Cutaneous Microvascular Functional Reserve Is Associated with Kidney Function and Histopathologic Injury: The MAP-CKD Study
Efficacy and Safety of Revascularization in Patients with Chronic Limb-Threatening Ischemia, Stratified by Kidney Function
Use of Selective Serotonin Reuptake Inhibitors and Inflammation-Associated Cardiovascular Risk in CKD
Association of Baseline Blood Pressure with Adverse Outcomes in Persons with CKD in the NURTuRE-CKD Study
Discriminative Performance of B-Type Natriuretic Peptide (BNP), Carbohydrate Antigen-125 (CA-125), Bioimpedance, and Venous Excess Ultrasound for Detecting Congestion in Nondialysis-Dependent CKD Stage 5: A Two-Center Pilot Study
Directly Measured Urinary Sodium and Blood Pressure in Korean Patients with CKD: The K-SALT Study
Two-Pronged Success: High Medication Possession Ratio of Potassium Binders Enables Normokalemia and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors: 12-Week Results from the HK-QIP Study
Utility of Simultaneous Measurement of 24-Hour Ambulatory Brachial and Central Blood Pressure in CKD
Serum Aldosterone and Kidney and Cardiovascular Outcomes in US Veterans
CKD Remission at Two Years and Long-Term Kidney, Cardiovascular, and Mortality Outcomes
Metabolic-Dysfunction Associated CKD: Is It a Real Entity?
Acute Change in Kidney Function After Concomitant Initiation of SGLT2 Inhibitors and RAAS Inhibitors: A Retrospective Case-Control Study
Time-Dependent Predictive Accuracy of Noninvasive Liver Scores for CKD Onset in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Longitudinal Cohort Study
Continuous Glucose Monitoring and Survival in a National CKD Cohort
A Composite Triglyceride-Glucose-Body Roundness Index (TyG-BRI) Predicts CKD and All-Cause Mortality Beyond Conventional Risk Factors: NHANES, 1999-2018
Glycemic Control and Subclinical Kidney Injury in Patients Enrolled in a Nephroprotection Program
Joint Trajectories of Body Mass Index and Waist-to-Hip Ratio and Cardiovascular Outcomes in CKD: Result from the KNOW-CKD Study
SGLT2 Inhibitors Reduce CKD Progression: A Meta-Analysis of Major Randomized Controlled Trials
GLP-1 Receptor Agonists and Kidney Outcomes Across the CKD Spectrum: A Real-World Taiwanese Cohort
Kidney Outcomes with Empagliflozin 10 mg vs. 25 mg: A Large, Real-World Retrospective Cohort Study
Novel Integration of Pathologic Features in Assessing Finerenone for CKD: Effectiveness and Safety from a Retrospective, Real-World Study
Effects of Finerenone on Clinical Outcomes by CKD Severity: A FIND-CKD Analysis
Comparative Effectiveness of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Insulin Glargine on Glycemic Control and Incident Retinopathy in a National Cohort of Veterans with Type 2 Diabetes (T2D) and CKD
Association of GLP-1 Receptor Agonist with Risk of Frailty-Related Outcomes in CKD
Effect of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on Vasodilatory Function of Renal Vessels
Effect of Finerenone on Risk Biomarkers of CKD Progression: A FIND-CKD Analysis
Hyperkalemia in Finerenone-Treated Patients with CKD: A FIND-CKD Analysis
Real-World Effect of SGLT2 Inhibitors on CKD Stage Transitions in Taiwan
Barriers and Facilitators to SGLT2 Inhibitor Use for CKD in Primary Care: Insights from a Veterans Health Administration Rural Community of Practice
Postoperative Sepsis and Hospital-Acquired Infection by Level of Kidney Function: A Population-Based Cohort Study
Serum Antibody Responses to the 20-Valent Pneumococcal Conjugate Vaccine Across CKD Stages and Dialysis
Nasal Antibody Responses to the 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Patients with CKD and Patients on Dialysis
Negative Creatinine and Cystatin C eGFR Discordance in HIV
Kidney Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV Across Baseline eGFR Subgroups: Five-Year Real-World Data from the BICSTaR Study
Tenofovir-Associated Progressive Kidney Failure Reversed After Transition from Bictegravir/Emtricitabine/Tenofovir Alafenamide to Long-Acting Cabotegravir/Rilpivirine
Comparative Effects of Ferric Citrate and Sevelamer on Protein-Bound Uremic Toxins in Patients with Nondialysis-Dependent CKD and Hyperphosphatemia: A Randomized Controlled Trial
Randomized Controlled Trial of Thiazide Diuretics, Calcium Polystyrene Sulfonate, and Sodium Zirconium Cyclosilicate for Hyperkalemia in CKD
Association of Protein Intake with Serum Potassium Concentration in CKD
Mechanisms of Behavior Change and Treatment Adherence in Patients with CKD and Comorbid Depression
Home-Based, Personalized Exercise Intervention Improves Mitochondrial Gene Expression and Decreases Fibroadipogenic Progenitor Cells in Persons with CKD
Effect of Sulforaphane and GSTM1 Genotype on Plasma 8-Isoprostane: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Effect of CKD on Periodontal Remodelling: Mechanisms and Clinical Relevance
Efficacy of Selective Serotonin Reuptake Inhibitors on Depression Outcomes in CKD: A Systematic Review and Meta-Analysis
Validation of a Simple Oral Protein-Loading Protocol for Glomerular Functional Reserve Assessment
Gastrointestinal Dialysis in Patients with Advanced CKD Who Decline Kidney Replacement Therapy
Prevalence and Clinical and Demographic Profile of Obstructive Sleep Apnea in Patients with Advanced Nondialysis-Dependent CKD at a Tertiary Care Hospital